Literature DB >> 1906768

Human vascular smooth muscle cells inhibit platelet aggregation when incubated with glyceryl trinitrate: evidence for generation of nitric oxide.

N Benjamin1, J A Dutton, J M Ritter.   

Abstract

1. The effect on platelet aggregation of glyceryl trinitrate in the presence of cultured vascular smooth muscle cells was determined turbidometrically. U46619 (a thromboxane mimetic) was used as agonist and experiments were performed in the presence of aspirin. Inorganic nitrite production from glyceryl trinitrate by vascular smooth muscle cells was also measured, to provide an indirect index of nitric oxide synthesis. 2. The combination of vascular smooth muscle cells together with glyceryl trinitrate, at concentrations that had little effect individually, profoundly inhibited platelet aggregation. 3. The inhibitory effect on platelet aggregation of vascular smooth muscle cells together with glyceryl trinitrate was markedly attenuated by haemoglobin, an inhibitor of nitric oxide. 4. These results show that vascular smooth muscle cells inhibit platelet aggregation when exposed to glycerol trinitrate and suggest that this is due to generation of nitric oxide from glyceryl trinitrate by vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906768      PMCID: PMC1917966          DOI: 10.1111/j.1476-5381.1991.tb12264.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts.

Authors:  N L Baenziger; P R Becherer; P W Majerus
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

3.  The Action as Poisons of Nitrites and other Physiologically Related Substances.

Authors:  J Haldane; R H Makgill; A E Mavrogordato
Journal:  J Physiol       Date:  1897-03-17       Impact factor: 5.182

4.  The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

5.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

6.  N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin.

Authors:  J Loscalzo
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

8.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

9.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.

Authors:  M Feelisch; E A Noack
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

10.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

View more
  11 in total

Review 1.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

2.  Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.

Authors:  D Salvemini; A Pistelli; E Anggard
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.

Authors:  P M Bath
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

4.  Release of nitric oxide from glyceryl trinitrate by captopril but not enalaprilat: in vitro and in vivo studies.

Authors:  D Salvemini; A Pistelli; V Mollace
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

5.  Cultured astrocytoma cells generate a nitric oxide-like factor from endogenous L-arginine and glyceryl trinitrate: effect of E. coli lipopolysaccharide.

Authors:  D Salvemini; V Mollace; A Pistelli; E Anggård; J Vane
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

6.  Time-dependent inhibition by glyceryl trinitrate of platelet aggregation caused by U46619 (a thromboxane/endoperoxide receptor agonist).

Authors:  G Kampf; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

7.  Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.

Authors:  D Salvemini; A Pistelli; J Vane
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

8.  Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers.

Authors:  N H Wallén; P T Larsson; A Bröijersén; A Andersson; P Hjemdahl
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

9.  Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.

Authors:  D Salvemini; V Mollace; A Pistelli; E Anggard; J Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

Review 10.  The platelet fibrinogen receptor: from megakaryocyte to the mortuary.

Authors:  Christopher N Floyd; Albert Ferro
Journal:  JRSM Cardiovasc Dis       Date:  2012-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.